These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20671370)

  • 41. Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins.
    Petzelbauer E; Seiffert D; Beckmann R; Pusch B; Geiger M; Binder BR
    Thromb Res; 1992 Jun; 66(5):559-67. PubMed ID: 1381850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulfated polysaccharide from the leaves of Artemisia Princeps activates heparin cofactor II independently of the Lys173 and Arg189 residues of heparin cofactor II.
    Hayashi T; Hayakawa Y; Hayashi T; Sasaki H; Sakuragawa N
    Thromb Res; 1997 Jul; 87(1):105-12. PubMed ID: 9253805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of a thrombin anion-binding exosite-2 mutant by the glycosaminoglycan-dependent serpins protein C inhibitor and heparin cofactor II.
    Cooper ST; Rezaie AR; Esmon CT; Church FC
    Thromb Res; 2002 Jul; 107(1-2):67-73. PubMed ID: 12413592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
    Hayashi T; Kaji T; Hayakawa Y; Niiya K; Sakamoto M; Sakuragawa N
    Thromb Res; 1991 Nov; 64(3):321-30. PubMed ID: 1805447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of chemotactic peptides by neutrophil degradation of heparin cofactor II.
    Corbin LW; Church FC; Hoffman M
    Thromb Res; 1990 Jan; 57(1):77-85. PubMed ID: 2300926
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus.
    Toulon P; Lamine M; Ledjev I; Guez T; Holleman ME; Sereni D; Sicard D
    Thromb Haemost; 1993 Nov; 70(5):730-5. PubMed ID: 8128426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Murine heparin cofactor II: purification, cDNA sequence, expression, and gene structure.
    Zhang GS; Mehringer JH; Van Deerlin VM; Kozak CA; Tollefsen DM
    Biochemistry; 1994 Mar; 33(12):3632-42. PubMed ID: 7908224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular cloning and expression of rabbit heparin cofactor II: a plasma thrombin inhibitor highly conserved between species.
    Sheffield WP; Schuyler PD; Blajchman MA
    Thromb Haemost; 1994 Jun; 71(6):778-82. PubMed ID: 7974347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of heparin cofactor II in the modulation of hemostasis.
    Salem HH; Thompson EA
    Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteolytic activation transforms heparin cofactor II into a host defense molecule.
    Kalle M; Papareddy P; Kasetty G; Tollefsen DM; Malmsten M; Mörgelin M; Schmidtchen A
    J Immunol; 2013 Jun; 190(12):6303-10. PubMed ID: 23656734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dynamic changes and localization of plasma heparin cofactor II before and after delivery in hypertensive pregnancy].
    Chen X; Zhang G; Wang C
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):468-70. PubMed ID: 11721410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanism of activation of heparin cofactor II by calcium spirulan.
    Hayakawa Y; Hirashima Y; Yamamoto H; Kurimoto M; Hayashi T; Lee JB; Endo S
    Arch Biochem Biophys; 2003 Aug; 416(1):47-52. PubMed ID: 12859981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin-inhibitor complexes in the blood during and after delivery.
    Andersson T; Lorentzen B; Hogdahl H; Clausen T; Mowinckel MC; Abildgaard U
    Thromb Res; 1996 Apr; 82(2):109-17. PubMed ID: 9163064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altering heparin cofactor II at VAL439 (P6) either impairs inhibition of thrombin or confers elastase resistance.
    Cunningham MA; Bhakta V; Sheffield WP
    Thromb Haemost; 2002 Jul; 88(1):89-97. PubMed ID: 12152684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
    Sutherland JS; Bhakta V; Filion ML; Sheffield WP
    Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism.
    Baglin TP; Carrell RW; Church FC; Esmon CT; Huntington JA
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11079-84. PubMed ID: 12169660
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A.
    Lin WY; Zhu R; Zhang Z; Lu X; Wang H; He W; Hu Y; Tang L
    Mol Ther Nucleic Acids; 2021 Jun; 24():658-668. PubMed ID: 33996250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on the effect of calcium in interactions between heparin and heparin cofactor II using surface plasmon resonance.
    Zhang F; Wu Y; Ma Q; Hoppensteadt D; Fareed J; Linhardt RJ
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):249-57. PubMed ID: 15247982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.